(Q33332125)

25 July 2017

1 reference

title

Therapeutic apheresis in renal and metabolic diseases (English)

1 reference

25 July 2017

Winters JL

1

1 reference

25 July 2017

Pineda AA

series ordinal

2

1 reference

25 July 2017

McLeod BC

series ordinal

3

1 reference

25 July 2017

Grima KM

series ordinal

4

1 reference

25 July 2017

language of work or name

1 reference

1 January 2000

1 reference

Journal of Clinical Apheresis

25 July 2017

published in

1 reference

25 July 2017

volume

15

1 reference

25 July 2017

issue

1-2

1 reference

25 July 2017

page(s)

53-73

1 reference

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Susceptibility to anti-glomerular basement membrane disease is strongly associated with HLA-DRB1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Recovery from Goodpasture's syndrome after immunosuppressive treatment and plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

21 January 2018

Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Long-term follow-up of aggressively treated idiopathic rapidly progressive glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Haemolytic uraemic syndrome: prognostic factors in children over 3 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Escherichia coli O157:H7: clinical, diagnostic, and epidemiological aspects of human infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Prolongation of acute renal failure in two patients with hemolytic-uremic syndrome due to excessive plasma infusion therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasma infusion for hemolytic-uremic syndrome in children: results of a multicenter controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasma exchange in children with hemolytic-uremic syndrome at risk of poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

The role of plasma exchange in the treatment of severe forms of hemolytic-uremic syndrome in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasmapheresis—Adjunctive Treatment for Steroid-Resistant Rejection in Renal Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Recurrent focal glomerulosclerosis: natural history and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasma exchange in the treatment of early recurrent focal glomerulosclerosis after renal transplantation. Report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Usefulness of plasma exchange in recurrent nephrotic syndrome following renal transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Disappearance of proteinuria after immunoadsorption in a patient with focal glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Advances in heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Recurrent or persistent cardiac allograft rejection: therapeutic options and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Treatment of severe cardiac allograft rejection with extracorporeal photochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Targeting nonalloimmune-dependent pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasma exchange and the arterial blood ketone body ratio in patients with acute hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Pregnancy outcome in familial homozygous hypercholesterolemic females treated with long-term plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Assessment of currently available low-density lipoprotein apheresis systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Pharmacologic antidotes in critical care medicine: a practical guide for drug administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Current status of plasmapheresis in toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasma perfusion through charcoal in methylparathion poisoning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Massive cisplatin overdose by accidental substitution for carboplatin. Toxicity and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasmapheresis in the treatment of dialysis encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Heredopathia atactica polyneuritiformis (Refsum's disease). Experiences of dietary treatment and plasmapheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Refsum's disease: management by diet and plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasma exchange in the treatment of Refsum's disease (heredopathia atactica polyneuritiformis)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Refsum's disease: long term treatment preserves sensory nerve action potentials and motor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

Plasma exchange removes glycosphingolipid in Fabry disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291098-1101%282000%2915%3A1%2F2%3C53%3A%3AAID-JCA5%3E3.0.CO%3B2-W

10.1002/(SICI)1098-1101(2000)15:1/2<53::AID-JCA5>3.0.CO;2-W

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference